Peter S. Kim
Affiliations: | 2014 | Whitehead Institute for Biomedical Research | Merck & Co., Inc. |
| 2014- | Biochemistry | Stanford University School of Medicine, Palo Alto, CA, United States |
Area:
protein folding, structure of viral envelope proteinsWebsite:
https://profiles.stanford.edu/peterkimGoogle:
"Peter Kim"Bio:
http://www.nasonline.org/member-directory/members/3002006.html
https://chemh.stanford.edu/news/merck-research-labs-chief-peter-kim-join-department-biochemistry
Mean distance: 7.61 | S | N | B | C | P |
Parents
Sign in to add mentor| George Paul Hess | research assistant | 1977-1979 | Cornell | |
| (Undergraduate research) | ||||
| Robert Lesh Baldwin | grad student | 1985 | Stanford | |
| (Characterization of protein folding intermediates) | ||||
Children
Sign in to add trainee| Jon Staley | grad student | MIT | |
| Jonathan S. Weissman | grad student | MIT | |
| Erin K. O'Shea | grad student | 1992 | MIT |
| Pehr Harbury | grad student | 1994 | Stanford Medical School |
| Brenda A. Schulman | grad student | 1989-1996 | MIT (Cell Biology Tree) |
| Tetiana B. Hryn'ova | grad student | 2006 | Stanford |
| Benjamin N Bell | grad student | 2015-2021 | Stanford Medical School |
| Yu-Hsien Hwang Fu | post-doc | 2019- | Stanford Medical School |
| Duo Xu | post-doc | 2020- | Stanford Medical School (E-Tree) |
| Soohyun Kim | post-doc | 2021- | Stanford |
| Terrence G. Oas | post-doc | 1987-1990 | MIT |
| Kevin J Lumb | post-doc | 1991-1995 | MIT |
| Stephen C. Blacklow | post-doc | 1996 | Whitehead Institute (MIT) |
| Andrea G. Cochran | post-doc | 1992-1996 | Whitehead Institute for Biomedical Research (MIT) |
| Ton N.M. Schumacher | post-doc | 1994-1996 | Whitehead Institute for Biomedical Research (GenetiTree) |
| Olga V. Boudker | post-doc | 1999-2001 | Weil Cornell Medical College |
| Amy E. Keating | post-doc | 2002 | MIT |
| Graham S Erwin | post-doc | 2016-2018 | Stanford |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wu TT, Travaglini KJ, Rustagi A, et al. (2024) Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung. The Journal of Experimental Medicine. 221 |
| Xu D, Powell AE, Utz A, et al. (2024) Design of universal Ebola virus vaccine candidates via immunofocusing. Proceedings of the National Academy of Sciences of the United States of America. 121: e2316960121 |
| Xu D, Carter JJ, Li C, et al. (2024) Vaccine design via antigen reorientation. Nature Chemical Biology |
| Xu D, Powell AE, Utz A, et al. (2023) Design of universal Ebola virus vaccine candidates immunofocusing. Biorxiv : the Preprint Server For Biology |
| Hie BL, Shanker VR, Xu D, et al. (2023) Efficient evolution of human antibodies from general protein language models. Nature Biotechnology |
| Bruun TJ, Tang S, Erwin G, et al. (2023) Structure-guided stabilization improves the ability of the HIV-1 gp41 hydrophobic pocket to elicit neutralizing antibodies. The Journal of Biological Chemistry. 103062 |
| Bell BN, Bruun TUJ, Friedland N, et al. (2023) HIV-1 prehairpin intermediate inhibitors show efficacy independent of neutralization tier. Proceedings of the National Academy of Sciences of the United States of America. 120: e2215792120 |
| Xu D, Li C, Utz A, et al. (2022) Designing epitope-focused vaccines antigen reorientation. Biorxiv : the Preprint Server For Biology |
| Kim S, Filsinger Interrante MV, Kim PS. (2022) Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies. Journal of Virology. e0164722 |
| Powell AE, Xu D, Roth GA, et al. (2022) Multimerization of Ebola GPΔmucin on protein nanoparticle vaccines has minimal effect on elicitation of neutralizing antibodies. Frontiers in Immunology. 13: 942897 |